Behavioral sensitization following repeated intravenous nicotine administration: Gender differences and gonadal hormones

Pharmacology Biochemistry and Behavior

Volumn 64, Issue 4, 1999, Pages 827-839

  Booze, Rosemarie M ^a,c   Welch, Marian A ^c   Wood, Marcie L ^c   Billings, Katharyn A ^c   Apple, Stephanie R ^c   Mactutus, Charles F ^b,c  

^a UNIVERSITY OF KENTUCKY   (United States)

^b University of Kentucky   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Estrous cyclicity; IV administration; Rats; Tolerance

Indexed keywords

NICOTINE; SEX HORMONE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; CIGARETTE SMOKING; CONTROLLED STUDY; CYTOLOGY; DRUG SENSITIZATION; DRUG TOLERANCE; ESTRUS CYCLE; FEMALE; GONADECTOMY; GROOMING; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; VAGINA;

ANIMALS; BODY WEIGHT; ESTRUS; FEMALE; GANGLIONIC STIMULANTS; GONADAL STEROID HORMONES; INJECTIONS, INTRAVENOUS; MALE; MOTOR ACTIVITY; NICOTINE; NICOTINIC AGONISTS; OVARIECTOMY; RATS; RATS, SPRAGUE-DAWLEY; SEX CHARACTERISTICS; TIME FACTORS; VAGINA;

ANIMALIA; NICOTIANA TABACUM;

EID: 0032739864     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(99)00169-0     Document Type: Article

References (75)

1. Adir J., Miller R.P., Rotenberg K.S. Disposition of nicotine in the rat after intravenous administration. Res. Commun. Chem. Pathol. Pharmacol. 13:1976;173-183.
2. Barber P.V., Arnold A.G., Evans G. Recurrent hormone dependent chorea. Effects of oestrogens and progestogens Clin. Endocrinol. (Oxf.). 5:1976;291-293.
3. Battig K. Smoking and the behavioral effects of nicotine. Trends Pharmacol. Sci. 2:1981;145-147.
4. Beatty W.W. Gonadal hormones and sex differences in nonreproductive behaviors in rodents. Organizational and activational influences Horm. Behav. 12:1979;112-163.
5. Beckett A.H., Gorrod J.W., Jenner P. The effect of smoking on nicotine metabolism in vivo in man. J. Pharm. Pharmacol. 23:1971;55S-61S.
6. Benowitz, N. L.: Pharmacokinetic considerations in understanding nicotine dependence. Ciba Found. Symp. 152:186-200; discussion 200-209; 1990.
7. Benowitz N.L. Clinical pharmacology of inhaled drugs of abuse. Implications in understanding nicotine dependence NIDA Res. Monogr. 99:1990;12-29.
8. Benowitz N.L., Jacob P. III. Daily intake of nicotine during cigarette smoking. Clin. Pharmacol. Ther. 234:1984;153-155.
9. Benowitz N.L., Jacob P. III, Denaro C., Jenkins R. Stable isotope studies of nicotine kinetics and bioavailability. Clin. Pharmacol. Ther. 49:1991;270-277.
10. Benowitz N.L., Kuyt F., Jacob P. III. Circadian blood nicotine concentrations during cigarette smoking. Clin. Pharmacol. Ther. 32:1982;758-764.
11. Blake C.A., Norman R.L., Scaramuzzi R.J., Sawyer C.H. Inhibition of the proestrous surge of prolactin in the rat by nicotine. Endocrinology. 92:1973;1334-1338.
12. Blake C.A., Scaramuzzi R.J., Norman R.L., Kanematsu S., Sawyer C.H. Effect of nicotine on the proestrous ovulatory surge of LH in the rat. Endocrinology. 91:1972;1253-1258.
13. BMDP Statistical Software: Berkley, CA: University of California Press; 1990.
14. Booze R.M., Lehner A.F., Wallace D.R., Welch M.A., Mactutus C.F. Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized rats. Neurotoxicol. Teratol. 19:1997;7-15.
15. Boxenbaum H. Evolutionary biology, animal behavior, fourth dimensional space and the raison d'etre of drug metabolism and pharmacokinetics. Drug. Metab. Rev. 14:1983;1057-1097.
16. Bridges R.S. A quantitative analysis of the roles of dosage, sequence, and duration of estradiol and progesterone exposure in the regulation of maternal behavior in the rat. Endocrinology. 114:1984;930-940.
17. Burke, A. W.; Broadhurst, P. L.; Behavioral correlates of oestrus cycle in the rat. Nature 209:223-224; 1966.
18. Butcher R.L., Collins W.E., Fugo N.W. Plasma concentration of LH, FSH, prolactin, progesterone and estradiol-17β throughout the 4-day estrous cycle of the rat. Endocrinology. 94:1974;1704-1708.
19. Clarke P.B.S., Kumar R. The effects of nicotine on locomotor activity in non-tolerant and tolerant rats. Br. J. Pharmacol. 78:1983;329-337.
20. Cohen J. Statistical power analysis for the behavioral sciences. 1988;Lawrence Erlbaum Associates, Hillsdale, NJ.
21. Collins A.C., Miner L.L., Marks M.J. Genetic influences on acute responses to nicotine and nicotine tolerance in the mouse. Pharmacol. Biochem. Behav. 30:1988;269-278.
22. Cronan T., Conrad J., Bryson R. Effects of chronically administered nicotine and saline on motor activity in rats. Pharmacol. Biochem. Behav. 22:1985;897-899.
23. Downs A.W., Eddy N.B. The effect of repeated doses of cocaine on the rat. J. Pharmacol. Exp. Ther. 46:1932;199-200.
24. Draper N.R., Smith H. Applied regression analysis. 2nd ed:1981;John Wiley & Sons, New York.
25. Emmett-Oglesby M.W. Sensitization and tolerance to motivational and subjective effects of psychostimulants. Hammer R.P. Jr. The neurobiology of cocaine. Cellular and molecular mechanisms:1995;31-47 CRC Press, Boca Raton.
26. Fray P.J., Sahakian B.J., Robbins T.W., Koob G.F., Iverson S.D. An observational method for quantifying the behavioral effects of dopamine agonists. Contrasting effects of d-amphetamine and apomorphine Psychopharmacology (Berlin). 69:1980;253-259.
27. Gibaldi M. Biopharmaceutics and clinical pharmacokinetics. 4th ed:1991;Lea & Febiger, Philadelphia.
28. Greenhouse S.W., Geisser S. On methods in the analysis of profile data. Psychometrika. 24:1959;95-112.
29. Gritz E.R., Nielsen I.R., Brooks L.A. Smoking cessation and gender. The influence of physiological, psychological and behavioral factors J. Am. Med. Womens Assoc. 51:1996;35-42.
30. Grunberg N.E., Bowen D.J., Winders S.E. Effects of nicotine on body weight and food consumption in female rats. Psychopharmacology (Berlin). 90:1986;101-105.
31. Grunberg N.E., Winders S.E., Popp K.A. Sex differences in nicotine's effects on consummatory behavior and body weight in rats. Psychopharmacology (Berlin). 91:1987;221-225.
32. Grunberg N.E., Winders S.E., Wewers M.E. Gender differences in tobacco use. Health Psychol. 10:1991;143-153.
33. Gumbelton M., Bent L.Z. Drug metabolism and laboratory anesthetic protocols in the rat. Antipyrine pharmacokinetics Pharm. Res. 8:1991;544-546.
34. Gumbelton M., Nicholls P.J., Taylor G. Differential effects of anesthesia regimens on gentamicin pharmacokinetics in the rat. A comparison with chronically catheterized conscious animals Pharm. Res. 7:1990;41-45.
35. 14C-labeled nicotine in mice and rats. J. Pharmacol. Exp. Ther. 137:1962;91-102.
36. Heishman S.J., Taylor R.C., Henningfield J.E. Nicotine and smoking. A review of effects on human performance Exp. Clin. Psychopharmacol. 2:1994;345-395.
37. Henningfield J.E., Keenan R.M. Nicotine delivery kinetics and abuse liability. J. Consult. Clin. Psychol. 61:1993;743-750.
38. Henningfield J.E., Stapleton J.M., Benowitz N.L., Grayson R.F., London E.D. Higher levels of nicotine in arterial than in venous blood after cigarette smoking. Drug Alcohol Depend. 33:1993;23-29.
39. Huang C.S.-H., Boudinot F.D., Feldman S. Effects of gender, pregnancy, and anesthesia on the pharmacokinetics of zidovudine in rats. Pharm. Res. 12:1995;1647-1651.
40. Jacob P. III, Yu L., Wilson M., Benowitz N.L. Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs. Absence of an isotope effect in the clearance of (S)-nicotine-3′,3′-d2 in humans Biol. Mass Spectrom. 20:1991;247-252.
41. Kalivas P.W. Neural basis of behavioral sensitization to cocaine. Hammer R.P. Jr. The neurobiology of cocaine. Cellular and molecular mechanisms:1995;81-98 CRC Press, Boca Raton, FL.
42. Kalivas P.W., Stewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res. Rev. 16:1991;223-244.
43. Kalivas P.W., Weber B. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J. Pharmacol. Exp. Ther. 245:1988;1095-1102.
44. Kanyt L. Stolerman, I. P.; Chandler, C. J.; Saigusa, T.; Pogun, S. Influence of sex and female hormones on nicotine-induced changes in locomotor activity in rats Pharmacol. Biochem. Behav. 62:1999;179-187.
45. Kanyt, L.; Tapkfran, D.; Furedy, J. J.; Kulal, B.; McDonald, R.; Pogun, S.: Nicotine interacts with sex in affecting rat choice between "look-out" and "navigational" cognitive styles in the Morris Water Maze place learning task. Brain Res. Bull. (in press).
46. Ksir C., Hakan R.L., Keller K.J. Chronic nicotine and locomotor activity. Influences of exposure dose and test dose Psychopharmacology (Berlin). 92:1987;25-29.
47. Kyerematen G.A., Vesell E.S. Metabolism of nicotine. Drug. Metab. Rev. 23:1991;3-41.
48. LaBella F.S., Queen G. General anesthetics inhibit cytochrome P450 monoxygen-ases and arachidonic acid metabolism. Can. J. Physiol. Pharmacol. 71:1993;48-53.
49. Levin E.D., Morgan M.M., Galvez C., Ellison G.D. Chronic nicotine and withdrawal effects on body weight and food and water consumption in female rats. Physiol. Behav. 39:1987;441-444.
50. Lin J.H. Species similarities and differences in pharmacokinetics. Drug Metab. Dispos. 23:1995;1008-1021.
51. Loch J.M., Potter J., Bachmann K.A. The influence of anesthetic agents on rat hepatic cytochromes P450 in vivo. Pharmacology. 50:1995;146-153.
52. Mactutus C.F., Herman A.S., Booze R.M. Chronic intravenous model for studies of drug (ab)use in the pregnant and/or group-housed rat. An initial study with cocaine Neurotoxicol. Teratol. 16:1994;183-191.
53. Miller R.P., Rotenberg K.S., Adir J. Effect of dose on the pharmacokinetics of intravenous nicotine in the rat. Drug. Metab. Dispos. 5:1977;436-443.
54. Morrison C.F., Stephenson J.A. The occurrence of tolerance to a central depressing effect of nicotine. Br. J. Pharmacol. 45:1972;151-156.
55. Nau H. Species differences in pharmacokinetics and drug teratogenesis. Environ. Health Perspect. 70:1986;113-129.
56. Perkins K.A., Grobe J.E., D'Amico D., Fonte C., Wilson A., Stiller R.L. Low-dose nicotine spray use and effects during initial smoking cessation. Exp. Clin. Psychopharmacol. 2:1996;157-165.
57. Porchet H.C., Benowitz N.L., Sheiner L.B. Pharmacodynamic model of tolerance. Application to nicotine J. Pharmacol. Exp. Ther. 244:1988;231-236.
58. Post R.M. Intermittent versus continuous stimulation. Effect of time interval on the development of sensitization or tolerance Life Sci. 26:1980;1275-1282.
59. Post R.M., Contel N.R. Human and animal studies of cocaine. Implications for development of behavioral pathology Creese I. Stimulants. Neurochemical, behavioral and clinical perspectives:1983;169-203 Raven Press, New York.
60. Rodier W.T. Progesterone-estrogen interactions in the control of activity-wheel running in the female rat. J. Comp. Physiol. Psychol. 74:1971;365-373.
61. Rosecrans J.A. Effects of nicotine on behavioral arousal and brain 5-hydroxytryptamine function in female rats selected for differences in activity. Eur. J. Pharmacol. 14:1971;29-37.
62. Rosecrans J.A. Brain area nicotine levels in male and female rats with different levels of spontaneous activity. Neuropharmacology. 11:1972;863-870.
63. Russell M.A., Feyerabend C. Cigarette smoking. A dependence on high-nicotine boli Drug Metab. Rev. 8:1978;29-57.
64. Schepers G., Rustemeir K., Walk R.-A., Hakenberg Metabolism of S-nicotine in noninduced and Aroclor-induced rats. Eur. J. Drug Metabol. Pharmacokinet. 18:1993;187-197.
65. Siegel S. Nonparametric statistics for the behavioral sciences. 1956;McGraw-Hill, New York.
66. Stolerman I.P., Garcha H.S., Mirza N.R. Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology (Berlin). 117:1995;430-437.
67. Tsujimoto A., Nakashima T., Tanino S., Dohi T., Kurogochi Y. Tissue distribution of [3H] nicotine in dogs and rhesus monkeys. Toxicol. Appl. Pharmacol. 32:1975;21-31.
68. U.S. Department of Health and Human Services: The health consequences of smoking: Nicotine addiction. A report of the Surgeon General. Rockville, MD: DHHS Publication No. (CDC) 88-8406, 1988.
69. Van Haaren F., Meyer M.E. Sex differences in locomotor activity after acute and chronic cocaine administration. Pharmacol. Biochem. Behav. 39:1991;923-927.
70. Waldron I. Patterns and causes of gender differences in smoking. Soc. Sci. Med. 32:1991;989-1005.
71. 3 receptors Synapse. 23:1996;152-163.
72. Wang, G. H.: The relation between spontaneous activity and oestrous cycle in the white rat. Comp. Psychol. Monogr. 2:1923.
73. Weeks J.R. Long-term intravenous infusion. Meyers R.D. Methods in Psychobiology, vol. 2. 1972;155-168 Academic Press, London.
74. Winer B.J. Statistical principles in experimental design. 1971;McGraw-Hill, New York.
75. Zahniser N.R., Peris J. Neurochemical mechanisms of cocaine-induced sensitization. Lakoski J.M., Galloway M.P., White F.J. Cocaine; Pharmacology, physiology, and clinical strategies. 1992;229-260 CRC Press, Boca Raton, FL.